Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pharma-Bio Serv (PBSV) Gross Profit (2016 - 2026)

Pharma-Bio Serv (PBSV) has disclosed Gross Profit for 15 consecutive years, with $748935.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Gross Profit rose 3.08% year-over-year to $748935.0, compared with a TTM value of $2.9 million through Oct 2025, up 15.66%, and an annual FY2025 reading of $2.9 million, up 15.66% over the prior year.
  • Gross Profit was $748935.0 for Q4 2025 at Pharma-Bio Serv, up from $574262.0 in the prior quarter.
  • Across five years, Gross Profit topped out at $1.6 million in Q3 2023 and bottomed at $535609.0 in Q1 2024.
  • Average Gross Profit over 5 years is $1.0 million, with a median of $1.2 million recorded in 2022.
  • The sharpest move saw Gross Profit crashed 59.01% in 2024, then soared 43.41% in 2025.
  • Year by year, Gross Profit stood at $1.5 million in 2021, then decreased by 26.04% to $1.1 million in 2022, then dropped by 16.13% to $929805.0 in 2023, then fell by 21.86% to $726570.0 in 2024, then rose by 3.08% to $748935.0 in 2025.
  • Business Quant data shows Gross Profit for PBSV at $748935.0 in Q4 2025, $574262.0 in Q3 2025, and $818726.0 in Q2 2025.